Katie Woods, MBBS, MRCP, M.D. - Pediatric Endocrinology

Dr. Woods’ research interests lie in the area of growth, particularly the physiology and the molecular pathology of the growth hormone (GH)- insulin-like growth factor -I (IGF-I) axis. Dr Woods has characterized several pathologic mutations in the genes involved the regulation of the GH-IGF axis, and described phenotype-genotype associations in GH receptor deficiency. Dr. Woods was instrumental in the identification and characterization of the first human case of a mutation in the IGF-1 gene in man, which provided important insights into IGF-I functioning in the human in both pre-and postnatal life. She is currently pursuing genetic studies in subjects with IGF deficient short stature, and is involved in clinical trials of recombinant IGF-I therapy in human subjects.

To schedule an appointment please call: 503-418-5710

 

Professional Education Degree:

  • MBBS (US equivalent MD): St. Bartholomew's Medical College, London, 1998
  • MD (US equivalent PhD): St. Bartholomew's Medical College, London, 1997
  • Residency: Pediatrics, Great Ormond Street Hospital and Queen Elizabeth Hospital for Sick Children, London, 1989-1993
  • Fellowship: Pediatric Endocrinology St. Bartholomew's Hospital, London, and John Radcliffe Hospital, University of Oxford, 1993-1998

    Certifications

    • Pediatric Endocrinology Subspecialty Certification, UK (UK equivalent to board certification)
    • General Pediatric Certification, UK (UK equivalent to board certificatIon)
    • MRCP, UK ( UK equivalent to US boards)

      Back to Visiting Specialists »

      What do you think?

      As the premier pediatric practice in Central Oregon, COPA constantly strives to improve and exceed the expectations of the families we serve. Any feedback on those things we are doing well or on ways we can improve our service is greatly appreciated.

      Give COPA Feedback